RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
5.61
+0.06 (1.08%)
At close: Jul 20, 2026, 4:00 PM EDT
5.63
+0.02 (0.36%)
After-hours: Jul 20, 2026, 4:53 PM EDT
RxSight Employees
RxSight had 461 employees as of December 31, 2025. The number of employees decreased by 37 or -7.43% compared to the previous year.
Employees
461
Change (1Y)
-37
Growth (1Y)
-7.43%
Revenue / Employee
$276,523
Profits / Employee
-$101,167
Market Cap
232.23M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 461 | -37 | -7.43% |
| Dec 31, 2024 | 498 | 124 | 33.16% |
| Dec 31, 2023 | 374 | 82 | 28.08% |
| Dec 31, 2022 | 292 | 71 | 32.13% |
| Dec 31, 2021 | 221 | 50 | 29.24% |
| Mar 31, 2021 | 171 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| InfuSystem Holdings | 473 |
| Treace Medical Concepts | 450 |
| Quanterix | 450 |
| Apyx Medical | 205 |
| Sight Sciences | 186 |
| 908 Devices | 172 |
| Profound Medical | 162 |
| Quantum-Si incorporated | 145 |
RXST News
- 5 days ago - RxSight Tarsus CEO Ron Kurtz to depart role, Aziz Mottiwala to succeed - TheFly
- 5 days ago - RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer - GlobeNewsWire
- 12 days ago - Law Offices of Howard G. Smith Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors - Business Wire
- 13 days ago - RxSight reports preliminary Q2 revenue $32M-$34M, consensus $32.07M - TheFly
- 13 days ago - RxSight raises FY26 revenue view to $140M-$160M from $120M-$135M - TheFly
- 13 days ago - RxSight price target lowered to $6.50 from $7.50 at Jefferies - TheFly
- 13 days ago - The Law Offices of Frank R. Cruz Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors - Business Wire
- 13 days ago - RxSight price target lowered to $6.50 from $8 at BofA - TheFly